ciclopirox has been researched along with Disease Models, Animal in 9 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciclopirox is a synthetic hydroxypyridone antifungal agent." | 6.41 | Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. ( Bohn, M; Kraemer, KT, 2000) |
| "Congenital erythropoietic porphyria is a rare autosomal recessive disease produced by deficient activity of uroporphyrinogen III synthase, the fourth enzyme in the heme biosynthetic pathway." | 5.48 | Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria. ( Anguita, J; Ben Bdira, F; Bernardo-Seisdedos, G; Blouin, JM; Castilla, J; de Verneuil, H; Díez, E; Dubus, P; Eraña, H; Falcón-Pérez, JM; García, S; González, E; González-Muñiz, R; Gutiérrez-de-Juan, V; Laín, A; Macías, I; Mato, JM; Millet, O; Moreno, J; Ortega, G; Oyarzábal, J; Pluta, P; Richard, E; Rodríguez-Cuesta, J; San Juan, I; Sanz-Parra, A; Urquiza, P, 2018) |
| "Ciclopirox is a synthetic hydroxypyridone antifungal agent." | 2.41 | Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. ( Bohn, M; Kraemer, KT, 2000) |
| "Congenital erythropoietic porphyria is a rare autosomal recessive disease produced by deficient activity of uroporphyrinogen III synthase, the fourth enzyme in the heme biosynthetic pathway." | 1.48 | Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria. ( Anguita, J; Ben Bdira, F; Bernardo-Seisdedos, G; Blouin, JM; Castilla, J; de Verneuil, H; Díez, E; Dubus, P; Eraña, H; Falcón-Pérez, JM; García, S; González, E; González-Muñiz, R; Gutiérrez-de-Juan, V; Laín, A; Macías, I; Mato, JM; Millet, O; Moreno, J; Ortega, G; Oyarzábal, J; Pluta, P; Richard, E; Rodríguez-Cuesta, J; San Juan, I; Sanz-Parra, A; Urquiza, P, 2018) |
| "The treatment of dermatophytoses, including onychomycosis, has come a long way over the past few decades with the introduction of oral antifungals (e." | 1.43 | Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model. ( Ghannoum, M; Hager, C; Long, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| da Costa, B | 1 |
| Pippi, B | 1 |
| Berlitz, SJ | 1 |
| Carvalho, AR | 1 |
| Teixeira, ML | 1 |
| Külkamp-Guerreiro, IC | 1 |
| Andrade, SF | 1 |
| Fuentefria, AM | 1 |
| Bernier, KM | 1 |
| Morrison, LA | 1 |
| Urquiza, P | 1 |
| Laín, A | 1 |
| Sanz-Parra, A | 1 |
| Moreno, J | 1 |
| Bernardo-Seisdedos, G | 1 |
| Dubus, P | 1 |
| González, E | 1 |
| Gutiérrez-de-Juan, V | 1 |
| García, S | 1 |
| Eraña, H | 1 |
| San Juan, I | 1 |
| Macías, I | 1 |
| Ben Bdira, F | 1 |
| Pluta, P | 1 |
| Ortega, G | 1 |
| Oyarzábal, J | 1 |
| González-Muñiz, R | 1 |
| Rodríguez-Cuesta, J | 1 |
| Anguita, J | 1 |
| Díez, E | 1 |
| Blouin, JM | 1 |
| de Verneuil, H | 1 |
| Mato, JM | 1 |
| Richard, E | 1 |
| Falcón-Pérez, JM | 1 |
| Castilla, J | 1 |
| Millet, O | 1 |
| Kang, JA | 1 |
| Kim, S | 1 |
| Park, M | 1 |
| Park, HJ | 1 |
| Kim, JH | 1 |
| Park, S | 1 |
| Hwang, JR | 1 |
| Kim, YC | 1 |
| Jun Kim, Y | 1 |
| Cho, Y | 1 |
| Sun Jin, M | 1 |
| Park, SG | 1 |
| Long, L | 1 |
| Hager, C | 1 |
| Ghannoum, M | 1 |
| Monti, D | 1 |
| Saccomani, L | 1 |
| Chetoni, P | 1 |
| Burgalassi, S | 1 |
| Tampucci, S | 1 |
| Mailland, F | 1 |
| Saeftel, M | 1 |
| Sarite, RS | 1 |
| Njuguna, T | 1 |
| Holzgrabe, U | 1 |
| Ulmer, D | 1 |
| Hoerauf, A | 1 |
| Kaiser, A | 1 |
| Bohn, M | 1 |
| Kraemer, KT | 1 |
1 review available for ciclopirox and Disease Models, Animal
| Article | Year |
|---|---|
Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Topics: Administration, Topical; Animals; Antifungal Agents; Cattle; Ciclopirox; Clinical Trials as Topic; D | 2000 |
8 other studies available for ciclopirox and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.
Topics: Animals; Antifungal Agents; Ciclopirox; Clioquinol; Dermatomycoses; Disease Models, Animal; Drug Com | 2021 |
Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice.
Topics: Animals; Antiviral Agents; Ciclopirox; Cornea; Disease Models, Animal; Eye Diseases; Herpes Simplex; | 2018 |
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.
Topics: Allosteric Site; Animals; Biophysical Phenomena; Cell Line; Ciclopirox; Disease Models, Animal; Drug | 2018 |
Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly.
Topics: Animals; Antiviral Agents; Capsid; Ciclopirox; Crystallography, X-Ray; Disease Models, Animal; Drug | 2019 |
Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Ciclopirox; Disease Models, Animal; Guinea Pi | 2016 |
Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
Topics: Administration, Topical; Animals; Antifungal Agents; Cattle; Ciclopirox; Disease Models, Animal; Hoo | 2011 |
Piperidones with activity against Plasmodium falciparum.
Topics: Animals; Antimalarials; Ciclopirox; Disease Models, Animal; Malaria; Mice; Mice, Inbred BALB C; Mimo | 2006 |